Novartis AG will acquire U.S.-based cancer drugmaker Endocyte Inc for $2.1 billion in cash as the Swiss drugmaker expands its radiopharmaceuticals business, the companies said on Thursday.
https://ift.tt/2ynTyuF support@endlesssupplies.biz (Endless Supplies .Biz) October 18, 2018 at 01:51AM
No comments:
Post a Comment